Atom Investors LP Puma Biotechnology, Inc. Transaction History

Atom Investors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$6.5 - $10.73 $1.54 Million - $2.54 Million	-236,911 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$8.75 - $12.85 $1.27 Million - $1.87 Million	145,626 Added 159.53%	236,911 $2.55 Million
Q2 2019 Aug 14, 2019	BUY	$12.3 - $35.76 $728,787 - $2.12 Million	59,251 Added 184.96%	91,285 $1.16 Million
Q1 2019 May 15, 2019	BUY	$20.77 - $42.37 $665,346 - $1.36 Million	32,034 New	32,034 $1.24 Million

101

29M

50.6K

16.3K

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $125M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.